Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barrier Therapeutics, Inc.
Pharmaceutical firm joins NASDAQ Biotechnology Index
June 15th, 2005
Barrier Therapeutics, Inc., (BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, announced that it was added to the NASDAQ Biotechnology Index effective at market open on May 23, 2005. "We are honored and delighted to be selected to join the other leading companies in our industry that comprise the NASDAQ Biotechnology Index," said Geert Cauwenbergh, PhD, chairman and CEO. "We feel our inclusion in this index validates the strength of our organization, our employees, and our growth to date, including the acceleration of our commercial activities and the further advancement of our clinical programs." ...
Source: Physician Law Weekly (2005-06-15)
|
